Diabetes Diagnostics Market Is Predicted To Reach $38.98 Billion, Expanding At 7.3% CAGR Through 2030
What Are The Estimated Market Size And CAGR For The Diabetes Diagnostics Market Between 2026 And 2030?
The diabetes diagnostics market size has grown strongly in recent years. It will grow from $27.31 billion in 2025 to $29.39 billion in 2026 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to rising prevalence of diabetes, reliance on fingerstick blood glucose testing, growing hospital-based diagnostics, increasing awareness of glycemic control, expansion of diagnostic laboratories.
The diabetes diagnostics market size is expected to see strong growth in the next few years. It will grow to $38.98 billion in 2030 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to growth in continuous glucose monitoring usage, increasing adoption of homecare diagnostics, technological advancements in biosensors, rising healthcare expenditure, expansion of digital health ecosystems. Major trends in the forecast period include expansion of continuous glucose monitoring adoption, integration of smart and connected diagnostic devices, rising demand for home-based diabetes testing, increased focus on early diabetes screening programs, advancements in non-invasive glucose monitoring.
Claim Your Free Report Sample Today:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21167&type=smp
Which Primary Market Drivers Are Fueling Momentum In The Diabetes Diagnostics Market?
The higher prevalence of obesity is expected to propel the growth of the diabetes diagnostics market going forward. Obesity refers to an excessive accumulation of body fat that increases the risk of various health conditions, such as heart disease and diabetes. The higher prevalence of obesity is attributed to factors such as sedentary lifestyles, increased consumption of processed and high-calorie foods, genetic predisposition, and limited physical activity. Diabetes diagnostics support obesity management by identifying insulin resistance and glucose metabolism issues early, enabling timely interventions to prevent weight gain and related health complications. For instance, in May 2025, according to the Office for Health Improvement and Disparities, a UK-based government body, from 2023 to 2024, an estimated 64.5% of adults aged 18 and over in England were overweight or living with obesity, up from 64.0% in 2022 to 2023. Therefore, the higher prevalence of obesity is driving the growth of the diabetes diagnostics market.
What Major Market Segments Contribute To Shaping The Overall Framework Of The Diabetes Diagnostics Market?
The diabetes diagnostics market covered in this report is segmented —
1) By Product Type: Blood Glucose Meters, Continuous Glucose Monitoring Devices, Lancets, Test Strips, Other Product Types
2) By Diabetes Type: Diabetes I, Diabetes Ii, Gestational Diabetes
3) By End-User: Hospitals, Diagnostic Centers, Homecare Settings, Other End-Users
Subsegments:
1) By Blood Glucose Meters: Traditional Blood Glucose Meters, Smart Blood Glucose Meters, Bluetooth-Enabled Blood Glucose Meters
2) By Continuous Glucose Monitoring Devices: Wearable CGM Systems, Implantable CGM Systems, Flash Glucose Monitoring Devices
3) By Lancets: Single-Use Lancets, Multi-Use Lancets
4) By Test Strips: Standard Test Strips, Smart Test Strips
5) By Other Product Types: Hemoglobin A1c Testing Kits, Urine Glucose Test Strips, Blood Ketone Meters
Which Trends Are Expected To Steer The Evolution Of The Diabetes Diagnostics Market?
Major companies operating in the diabetes diagnostics market are focused on developing innovative products such as gestational diabetes diagnostics tools to expand their product portfolios and meet the growing demand for early detection and management of diabetes during pregnancy. A gestational diabetes diagnostic tool refers to medical devices or tests used to detect and monitor gestational diabetes in pregnant women, typically involving blood glucose testing, such as the oral glucose tolerance test (OGTT), to assess how well the body processes sugar during pregnancy. For instance, in August 2024, DirectSens GmbH, an Austria-based biotechnology company, launched XpressGT RUO kit, a groundbreaking biosensor tool designed for the detection of insulin resistance-related conditions such as gestational diabetes, endometriosis, and liver disease. The kit provides rapid results, measuring 2-hydroxybutyrate (2-HB) levels in venous blood, and is compatible with standard clinical analyzers. This innovation aims to offer early diagnostics, potentially improving outcomes for millions of patients worldwide.
Who Are The Established And Emerging Players Expanding Their Footprint In The Diabetes Diagnostics Market?
Major companies operating in the diabetes diagnostics market are F. Hoffmann-La Roche AG, Bayer AG, Abbott Laboratories, Medtronic plc, DexCom Inc, Tandem Diabetes Care Inc, Ypsomed AG, LifeScan Inc, Nova Biomedical Corporation, Ascensia Diabetes Care Holdings AG, ARKRAY Inc, PTS Diagnostics Inc, AgaMatrix Inc, Senseonics Holdings Inc, DarioHealth Corp, Bionime Corporation, Acon Laboratories Inc, Sinocare Inc, i‑SENS Inc, Prodigy Diabetes Care LLC, Rossmax International Ltd, Menarini Diagnostics s.r.l, Trividia Health Inc, EKF Diagnostics Holdings plc.
Get Your In-Depth Diabetes Diagnostics Market Report Now:
https://www.thebusinessresearchcompany.com/report/diabetes-diagnostics-global-market-report
Which Regions Demonstrate The Highest Growth Momentum In The Diabetes Diagnostics Market?
North America was the largest region in the diabetes diagnostics market in 2025. The regions covered in the diabetes diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Contact Us:
The Business Research Company: https://thebusinessresearchcompany.com/
Americas +1 310–496–7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Comments
Post a Comment